KW-2449

KW-2449 · Kyowa Kirin, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KW-2449, covering 2016-08-12 to 2024-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002) [Phase 1]

See pricing